Medical/Pharmaceuticals
The Adecco Group: Q3 22 RESULTS
- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange - Accelerated growth and market share momentum, robust profitability ZURICH, Nov. 3, 2022 /PRNewswire/ -- HIGHLIGHTS * Revenues +16% reported, +6% yoy organic TDA * Growth leadership in Adecco; relative revenue grow...
2022-11-03 15:12
2109
Announcement of the Effect of Ginseng and Red Ginseng for Memory Improvement and Suppression of Bone and Muscle Loss
* Effect of improving blood pressure in patients with high blood pressure and diabetes * Announced at the 13th International Symposium on Ginseng 2022 SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ -- Experts who have conducted scientific studies on the effect of ginseng gathered inSeoul from ...
2022-11-03 14:24
2239
Docquity digitized patient affordability programs in the Philippines, saving over US$1M for patients
More than 350 doctors have supported over 1,000 cancer patients to get improved and affordable care since the start of the pilot last year MANILA, Philippines, Nov. 3, 2022 /PRNewswire/ -- In support of the Philippine government's initiatives to promote universal healthcare, Docquity, Southeast ...
2022-11-03 13:08
2748
CCTV+: Lyrics of White Peony Root into the Air
BEIJING, Nov. 3, 2022 /PRNewswire/ -- Located in southeast China, Jiangxi is ringed on three sides by mountains, bordering rivers and lakes on the north. Mountains and hills undulate in the region, with large basins scattering in the middle. The complex and diverse terrain, is a cradle for a vari...
2022-11-03 12:48
2356
First SEA Genomic Data Digitisation Collaboration Formed to Improve Cancer Clinical Trial Access
SINGAPORE, Nov. 3, 2022 /PRNewswire/ -- Oncoshot has just announced one of its biggest collaborations to date with Icon Cancer Centre inSingapore, alongside Roche. Together the partners plan to facilitate more comprehensive genomic profiling data to increase access to more trial options for cance...
2022-11-03 11:51
2078
First in-human use of OncoRes Medical's cancer imaging system successful
Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research PERTH, Australia, Nov. 3, 2022 /PRNewswire/ -- OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled...
2022-11-03 06:00
1631
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer
Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars MOUNTAIN VIEW, Calif., Nov. 2, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today annou...
2022-11-02 21:00
2580
Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China
- ATG-037, an inhouse asset developed by Antengene and with global rights, has been approved to enter clinical studies inAustralia and China, thus becoming the firstoral small molecule CD73 inhibitor entering the clinical-stage in China and the wider Asia Pacific region. ATG-037 IND in Austr...
2022-11-02 20:07
2394
Dr Amit Kakar joins MedGenome Board of Directors
* The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. * The company had announced a $50 million Series D investment led by Novo Holdings inAugust 2022. BANGALORE, India, Nov. 2, 2022 /PRNewswire/ -- MedGenome is a leading provider of genomic solutions for populat...
2022-11-02 10:00
1923
NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
United States-based National Comprehensive Cancer Network enters strategic cooperation agreement with Chinese medical information website to publish and translate evidence-based expert consensus guidelines for cancer care; now available atnccnchina.org.cn. PLYMOUTH MEETING, Pa., Nov. 2, 2022 /PR...
2022-11-02 09:04
1826
Daewoong Pharmaceutical Presents Phase 3 Clinical Trial Results of New Diabetes Treatment 'Enavogliflozin' and Roadmap to Enter 50 Countries by 2030
* Highly anticipated to be an effective therapeutic for its excellent efficacies in reducing blood glucose levels and safety SEOUL, South Korea, Nov. 2, 2022 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong), the South Korea -based global healthcare company, announced the phase III clinical tri...
2022-11-02 09:00
1655
Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19
-- ASC11 is an in-house discovered oral small molecule drug candidate, targeting 3-chymotrypsin like protease (3CLpro) -- In antiviral cellular assays with infectious SARS-CoV-2, ASC11 demonstrated higher potency against SARS-CoV-2 than other 3CLpro inhibitors including Nirmatrelvir, S-217622, P...
2022-11-02 08:10
2067
SK pharmteco appoints Joerg Ahlgrimm as CEO to spearhead the next phase of company growth and innovation
- Joerg Ahlgrimm brings 25 years of expertise in pharmaceuticals and innovative cell and gene therapies - SK pharmteco expands pharmaceutical drug production and advances cell and gene therapy production - Annual sales expected to exceed KRW 1 trillion in 2022 FRANKFURT, Germany, Nov. 2, 2022 /PR...
2022-11-02 02:00
1793
OrthAlign, Inc. Adds Balance Feature to their Lantern® Platform, Including Indications for Primary and Revision Knee Arthroplasty
New feature offers soft-tissue balancing to aid in accurate component positioning ALISO VIEJO, Calif., Nov. 1, 2022 /PRNewswire/ -- With its recent addition of the Balance feature to the Lantern platform, OrthAlign, Inc. is delivering an efficient, easy-to-use, cost-effective instrument that aid...
2022-11-01 22:34
2153
Announcement of the Effect of Ginseng and Red Ginseng for Blood Pressure Improvement and Memory Improvement
SEOUL, South Korea, Nov. 1, 2022 /PRNewswire/ -- The Korean Society of Ginseng
(chaired byLee Man-hui) said that the 13th International Symposium on Ginseng
took place from the 25th to the 28th at Lotte Hotel Seoul.
2022-11-01 21:53
2832
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Receives NMPA Approval for the Treatment of sqNSCLC
SHANGHAI, Nov. 1, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that its first self-developed innovative anti-PD-1 monoclonal antibody (mAb) HANSIZHUANG (generic name: serplulimab injection), in combination with carboplatin and albumin-bound paclitaxel for the first-lin...
2022-11-01 21:32
3007
SPARK™ CLEAR ALIGNERS RELEASE 13 PROVIDES HIGHLY ANTICIPATED ORTHODONTIC INNOVATIONS WITH GROUND-BREAKING AND EXCLUSIVE CLINICAL FEATURES
– Doctor-Driven Innovation and Improvements Provide Superior Control, More Comprehensive Diagnosis and Treatment Planning – BREA, Calif., Nov. 2, 2022 /PRNewswire/ -- Ormco Corporation, a global leader and innovator of orthodontic products and solutions, today announced the launch of its Spark™ ...
2022-11-01 21:00
1745
Inteleos to Convene Global Health Leaders to Develop Community-Specific Ultrasound Programs Aimed at Lowering Maternal and Fetal Mortality Rates in Kenya
Alliance aims to reduce maternal mortality in Kenya by 10 percent in five years ROCKVILLE, Md., Nov. 1, 2022 /PRNewswire/ -- Inteleos™, and its global partners,Kenya Women and Children's Wellness Centre, The Kenya Healthcare Federation and HealthEd Global will host a Stakeholder Summit set for N...
2022-11-01 21:00
2148
Immuno Cure appoints new CFO
Strengthening of executive management team to propel growth strategy HONG KONG, Nov. 1, 2022 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the appointment of Mr M...
2022-11-01 20:18
2552
Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare Conference
SAN FRANCISCO, HOUSTON and SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced that Chief Financial OfficerJosh House and Chief Deve...
2022-11-01 20:00
1319
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
9352
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
6994
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
6107
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
5730
